Insiders Buying Eyenovia And 3 Other Stocks Under $2
Portfolio Pulse from Lisa Levin
Insiders at four companies with stocks under $2—Eyenovia, Retractable Technologies, Stereotaxis, and VerifyMe—have recently made notable purchases of their company's shares. These transactions can signal insider confidence and are often considered by investors when evaluating penny stocks. Stereotaxis and Retractable Technologies reported downbeat results, while VerifyMe and Eyenovia posted positive updates.
December 06, 2023 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Retractable Technologies' President and CEO Thomas J Shaw acquired 1,595 shares at $1.13 each. The company reported an operational loss for the first nine months of 2023.
The CEO's purchase might offset some negative sentiment from the reported losses, but the impact on the stock price is uncertain.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Stereotaxis Director Paul J Isaac bought 2,808 shares at $1.56 each. The company had downbeat quarterly results, which may affect investor sentiment.
The director's purchase shows confidence, but the recent poor quarterly results could keep the stock's short-term impact neutral.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Eyenovia's CEO Michael Rowe purchased 4,890 shares at $1.36 each. The company recently reported upbeat quarterly sales, which may bolster investor confidence.
The CEO's purchase combined with positive sales results could lead to a short-term positive impact on EYEN's stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
VerifyMe Director Marshall S Geller acquired 1,100 shares at $1.04 each. The company recently posted upbeat quarterly results, which may positively influence the stock.
The director's investment, along with positive quarterly results, suggests a potential short-term uptick in VRME's stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80